|
Questions and Answers on USP 797
Questions and
Answers on USP 797: Answers Provided by Eric S. Kastango,
MBA, RPh, FASHP:
-
E15 Question:
When
wiping down a laminar flow hood, are there any
specifications as to the type of wipes that are allowed?
-
E15 Answer:
The
language in the proposed changes in USP Chapter 797 says
"All cleaning tools, such as wipers, sponges, and mops,
are nonshedding and dedicated to use in the buffer or
clean area. Floor mops may be used in both the buffer or
clean area and anteroom area, but only in that order.
Most wipers are discarded after one use. If cleaning
tools are reused, their cleanliness is maintained by
thorough rinsing and disinfecting after use and by
storing in a clean environment between uses." There are
a number of vendors (ITW-TexWipe,
www.texwipes.com)
who
can provide you with more information about wipers.
(Answer provided as a courtesy
to usp797.org by Eric S. Kastango, MBA, RPh, FASHP. Please
note that usp797.org is not responsible for this answer.)
-
About Eric S. Kastango: Since its
inception, Eric S. Kastango has been at the forefront of
USP <797>. He is an elected member of the United States
Pharmacopoeia Sterile Compounding Committee (2005-2010).
Over the years, he has held multiple American Society of
Health-System Pharmacists chairmanships and committee
positions. He was responsible for creating the
“Comprehensive Sterile Compounding Compliance Gap
Analysis and Risk Assessment Tool.” In this capacity,
Mr. Kastango frequents pharmacy events as an expert
speaker, contributes to industry journals, and teaches.
Mr. Kastango received his Bachelor of Science in
Pharmacy degree from the Massachusetts College of
Pharmacy and Allied Health Sciences and a MBA from the
University of Phoenix. Since 1980, he has practiced
pharmacy in a number of practice settings (including
hospitals, community, and home care) in a number of
different of roles, including the Corporate Vice
President of Pharmacy Services for Coram Healthcare
Corporation, which has 72 pharmacies in 44 states. He
has also managed a FDA-registered cGMP manufacturing
operation for Baxter Healthcare Corporation, and has
made over 100 presentations on a variety of pharmacy
practice topics. Mr. Kastango is the President and CEO
of Clinical IQ, and can be reached as follows:
Mr. Eric
S. Kastango – President and CEO
Clinical IQ, LLC
184 Columbia Turnpike, #282
Florham Park, NJ 07932
Tel: (973) 765-9393
---
www.clinicaliq.com
|